...
首页> 外文期刊>MBio >UHRF1 Suppresses HIV-1 Transcription and Promotes HIV-1 Latency by Competing with p-TEFb for Ubiquitination-Proteasomal Degradation of Tat
【24h】

UHRF1 Suppresses HIV-1 Transcription and Promotes HIV-1 Latency by Competing with p-TEFb for Ubiquitination-Proteasomal Degradation of Tat

机译:UHRF1抑制HIV-1转录,并通过与P-TEFB竞争TAT的P-TEFB来促进HIV-1潜伏期

获取原文
           

摘要

ABSTRACT HIV-1 remains incurable due to viral reservoirs, which lead to durably latent HIV infection. Identifying novel host factors and deciphering the molecular mechanisms involved in the establishment and maintenance of latency are critical to discover new targets for the development of novel anti-HIV agents. Here, we show that ubiquitin-like with PHD and RING finger domain 1 (UHRF1) modulates HIV-1 5′-long terminal repeat (LTR)-driven transcription of the viral genome as a novel HIV-1 restriction factor. Correspondingly, UHRF1 depletion reversed the latency of HIV-1 proviruses. Mechanistically, UHRF1 competed with positive transcription factor b (p-TEFb) for the binding to the cysteine-rich motifs of HIV-1 Tat via its TTD, PHD, and RING finger domains. Furthermore, UHRF1 mediated K48-linked ubiquitination and proteasomal degradation of Tat in RING-dependent ways, leading to the disruption of Tat/cyclin T1/CDK9 complex and consequential impediment of transcription elongation. In summary, our findings revealed that UHRF1 is an important mediator of HIV-1 latency by controlling Tat-mediated transcriptional activation, providing novel insights on host-pathogen interaction for modulating HIV-1 latency, beneficial for the development of anti-AIDS therapies.
机译:由于病毒储层,摘要HIV-1仍然是可行的,这导致潜伏的艾滋病毒感染。识别新的宿主因子和解密所涉及的延迟建立和维护的分子机制对于发现新的抗HIV代理人的发展目标至关重要。在这里,我们表明泛素样与PHD和环形指导结构域1(UHRF1)调节病毒基因组的HIV-1 5'-长末端重复(LTR)作为新的HIV-1限制因子。相应地,UHRF1耗尽逆转了HIV-1潜水的潜伏期。机械地,UHRF1竞争阳性转录因子B(P-TEFB),用于通过其TTD,PHD和环形指导域与HIV-1 TAT的富含半胱氨酸的富泳型的结合。此外,UHRF1介导的K48连接的K48连接的泛素化和蛋白酶体降解TAT的环依赖性方式,导致TAT / CYCLIN T1 / CDK9复合物的破坏以及转录伸长的相应障碍。总之,我们的研究结果表明,UHRF1是通过控制TAT介导的转录激活来实现HIV-1潜伏期的重要介质,提供了对调节HIV-1等待时间的宿主病原体相互作用的新颖见解,有利于抗助助剂疗法的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号